Plain-English translation of NCT07198529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests whether using a special imaging tool called optical coherence tomography (OCT) during heart stent placement can help doctors decide how long patients need to take blood-thinning medications after the procedure. The study focuses on patients with stable angina (chest pain from reduced blood flow to the heart) who are receiving a cobalt-chromium everolimus-eluting stent. If the imaging shows the stent is perfectly positioned, patients may only need to take two blood thinners for one month, rather than the standard six to twelve months.
Older patients and those with other health conditions often face a difficult choice: taking blood thinners for longer protects against heart problems but increases bleeding risk. This trial is exploring whether detailed imaging during the stent procedure can identify which patients have perfect stent placement and can safely use shorter blood thinner therapy, reducing unnecessary bleeding complications.
You likely qualify if…
You likely don't qualify if…
During your heart stent procedure, doctors will use the special imaging tool to evaluate how well the stent is positioned and working. Based on the imaging results, you will be assigned to one of three groups: if your stent looks perfect, you'll take two blood thinners for one month then switch to one; if the stent placement is not quite optimal, you'll take two blood thinners for either six or twelve months depending on your individual bleeding and heart disease risk. You will have follow-up visits to monitor your health and check how you're doing on the blood thinner regimen.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
South Korea